Effects of miRNA-15 and miRNA-16 expression replacement in chronic lymphocytic leukemia : implication for therapy
dc.contributor.author | Cutrona, G. | |
dc.contributor.author | Matis, S. | |
dc.contributor.author | Colombo, M. | |
dc.contributor.author | Massucco, C. | |
dc.contributor.author | Baio, G. | |
dc.contributor.author | Valdora, F. | |
dc.contributor.author | Emionite, L. | |
dc.contributor.author | Fabris, S. | |
dc.contributor.author | Recchia, A. G. | |
dc.contributor.author | Gentile, M. | |
dc.contributor.author | Neumaier, C. E. | |
dc.contributor.author | Reverberi, D. | |
dc.contributor.author | Massara, R . | |
dc.contributor.author | Boccardo, S. | |
dc.contributor.author | Basso, L. | |
dc.contributor.author | Salvi, S. | |
dc.contributor.author | Rosa, F. | |
dc.contributor.author | Cilli, M. | |
dc.contributor.author | Zupo, S. | |
dc.contributor.author | Truini, M. | |
dc.contributor.author | Tassone, P. | |
dc.contributor.author | Calabrese, M. | |
dc.contributor.author | Negrini, M. | |
dc.contributor.author | Neri, A. | |
dc.contributor.author | Morabito, F. | |
dc.contributor.author | Fais, F. | |
dc.contributor.author | Ferrarini, M. | |
dc.date.accessioned | 2017-08-03T23:01:24Z | |
dc.date.available | 2017-08-03T23:01:24Z | |
dc.date.issued | 2017-09 | |
dc.identifier.citation | Cutrona , G , Matis , S , Colombo , M , Massucco , C , Baio , G , Valdora , F , Emionite , L , Fabris , S , Recchia , A G , Gentile , M , Neumaier , C E , Reverberi , D , Massara , R , Boccardo , S , Basso , L , Salvi , S , Rosa , F , Cilli , M , Zupo , S , Truini , M , Tassone , P , Calabrese , M , Negrini , M , Neri , A , Morabito , F , Fais , F & Ferrarini , M 2017 , ' Effects of miRNA-15 and miRNA-16 expression replacement in chronic lymphocytic leukemia : implication for therapy ' , Leukemia , vol. 31 , no. 9 , pp. 1894-1904 . https://doi.org/10.1038/leu.2016.394 | en |
dc.identifier.issn | 0887-6924 | |
dc.identifier.other | PURE: 86318613 | |
dc.identifier.other | PURE UUID: 1e520949-2054-41e7-8c3d-80e09bfc4261 | |
dc.identifier.other | Scopus: 85011566469 | |
dc.identifier.uri | http://hdl.handle.net/2164/9070 | |
dc.description | This work was supported by: Associazione Italiana Ricerca sul Cancro (AIRC) Grant 5 x mille n.9980, (to M.F., F.M. A. N., P.T. and M.N.) ; AIRC I.G. n. 14326 (to M.F.), n.10136 and 16722 (A.N.), n.15426 (to F.F.). AIRC and Fondazione CaRiCal co-financed Multi Unit Regional Grant 2014 n.16695 (to F.M.). Italian Ministry of Health 5x1000 funds (to S.Z. and F.F). A.G R. was supported by Associazione Italiana contro le Leucemie-Linfomi-Mielomi (AIL) Cosenza - Fondazione Amelia Scorza (FAS). S.M. C.M., M.C., L.E., S.B. were supported by AIRC. | en |
dc.format.extent | 11 | |
dc.language.iso | eng | |
dc.relation.ispartof | Leukemia | en |
dc.subject | R Medicine | en |
dc.subject | Biochemistry, Genetics and Molecular Biology(all) | en |
dc.subject | Medicine(all) | en |
dc.subject.lcc | R | en |
dc.title | Effects of miRNA-15 and miRNA-16 expression replacement in chronic lymphocytic leukemia : implication for therapy | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Postprint | en |
dc.identifier.doi | https://doi.org/10.1038/leu.2016.394 | |
dc.date.embargoedUntil | 2017-08-03 | |
dc.identifier.vol | 31 | en |
dc.identifier.iss | 9 | en |